MoneyWorks4Me

Mankind Pharma informs about earnings call

29 Oct 2025 Evaluate
Pursuant to Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that the Company will host Investor Conference Call on Thursday, November 6, 2025 at 06:00 pm (IST) for Q2 & H1 FY26. Details of the Investor Conference Call are enclosed. The same are also being uploaded on website of the Company at www.mankindpharma.com.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..